United Therapeutics Corporation - Common Stock (UTHR) stock analysis

UTHR · United Therapeutics Corporation - Common Stock

Latest recorded price: USD 587.88

Model-estimated fair value: USD 706.77. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

At $587.88, UTHR trades 16.8% below the model's base-case value of $706.77. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $543.66 in the conservative case and $903.34 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 18.0%, free cash flow margin 32.7%, ROIC 23.4%. The model flags 1 risk signal for this company.

Similar companies in Healthcare